MeSH D054143 - systolic heart failure
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Accord Healthcare | Eplerenone | Eplerenone | 2017-07-13 | |||
| Annora Pharma | Eplerenone | Eplerenone | 2023-06-02 | |||
| AstraZeneca | Dapagliflozin | Edistride | 2015-11-09 | |||
| Dapagliflozin | Forxiga | 2012-11-11 | ||||
| Breckenridge Pharmaceutical | Eplerenone | Eplerenone | 2018-09-14 | |||
| Chartwell Pharmaceuticals | Eplerenone | Eplerenone | 2008-07-30 | |||
| Prasco | Eplerenone | Eplerenone | 2017-02-02 | |||
| Rising Pharmaceuticals | Eplerenone | Eplerenone | 2022-03-23 | |||
| Sandoz | Eplerenone | Eplerenone | 2008-08-01 | |||
| Slate Run Pharmaceuticals | Eplerenone | Eplerenone | 2020-08-10 | |||
| Upjohn | Eplerenone | Inspra | 2002-09-27 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
80%4/5
Phase 2
27%3/11
Phase 3
36%5/14
Approved: 1Overall Success rate: 8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use